Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Glide Pharma's fifth round generates £14mm

Executive Summary

Glide Pharma (needle-free delivery of solid dose formulations of drugs and vaccines) raised £14mm ($21.4mm) in its fifth financing round led by first-time backer Invesco Perpetual, which was joined by returning shareholders. The company will use the money for scale-up manufacturing of the drug and device components of its Glide SDI solid dose injector system, and for ongoing development of its programs including epinephrine and teriparatide.
Deal Industry
  • Medical Devices
  • Pharmaceuticals
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
      • Controlled Release
      • Macromolecule
  • Biotechnology
    • Large Molecule
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies